Total Payments
$33,677
2020 Payments
$1,500
Companies
4
Transactions
55
Medicare Patients
869
Medicare Billing
$121,047
Payment Breakdown by Category
Consulting$19,950 (59.2%)
Other$9,130 (27.1%)
Travel$3,306 (9.8%)
Food & Beverage$1,291 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,950 | 5 | 59.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,100 | 2 | 15.1% |
| Honoraria | $4,030 | 1 | 12.0% |
| Travel and Lodging | $3,306 | 21 | 9.8% |
| Food and Beverage | $1,291 | 26 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $23,015 | 26 | $0 (2020) |
| AbbVie, Inc. | $6,429 | 26 | $0 (2017) |
| CSL Behring | $4,186 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $46.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $1,500 | 1 | Veloxis Pharmaceuticals, Inc. ($1,500) |
| 2019 | $9,750 | 1 | Veloxis Pharmaceuticals, Inc. ($9,750) |
| 2018 | $11,755 | 18 | Veloxis Pharmaceuticals, Inc. ($7,569) |
| 2017 | $10,672 | 35 | AbbVie, Inc. ($6,429) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunosuppressant | ||||||
| 09/15/2019 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Consulting Fee | Cash or cash equivalent | $9,750.00 | General |
| Category: IMMUNOSUPPRESSANT | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Travel and Lodging | In-kind items and services | $355.40 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Travel and Lodging | In-kind items and services | $301.28 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Travel and Lodging | In-kind items and services | $203.00 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Travel and Lodging | In-kind items and services | $144.00 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $69.68 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $48.63 | General |
| Category: Immunosuppressant | ||||||
| 11/30/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunosuppressant | ||||||
| 11/29/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $102.94 | General |
| Category: Immunosuppressant | ||||||
| 05/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Immunosuppressant | ||||||
| 05/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $68.95 | General |
| Category: Immunosuppressant | ||||||
| 05/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $46.10 | General |
| Category: Immunosuppressant | ||||||
| 05/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunosuppressant | ||||||
| 05/11/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunosuppressant | ||||||
| 05/10/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Travel and Lodging | In-kind items and services | $243.21 | General |
| Category: Immunosuppressant | ||||||
| 03/09/2018 | CSL Behring | — | Honoraria | Cash or cash equivalent | $4,030.00 | General |
| 03/09/2018 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $156.06 | General |
| 03/04/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $120.99 | General |
| Category: Immunosuppressant | ||||||
| 12/19/2017 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/19/2017 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $48.00 | General |
| 12/19/2017 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $22.47 | General |
| 12/19/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $5.28 | General |
| 12/19/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $4.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 196 | 294 | $81,842 | $27,393 |
| 2022 | 4 | 208 | 300 | $62,017 | $29,845 |
| 2021 | 6 | 246 | 409 | $80,235 | $39,877 |
| 2020 | 5 | 219 | 279 | $62,797 | $23,932 |
Total Patients
869
Total Services
1,282
Medicare Billing
$121,047
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 113 | 134 | $35,892 | $13,157 | 36.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 86 | $25,714 | $8,496 | 33.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $9,376 | $2,303 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 33 | $6,864 | $1,985 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 25 | $3,996 | $1,452 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 104 | 137 | $30,815 | $14,847 | 48.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 82 | $15,252 | $6,993 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 59 | $8,800 | $4,368 | 49.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 22 | $7,150 | $3,637 | 50.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 95 | 132 | $30,175 | $15,642 | 51.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 154 | $28,239 | $13,438 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 63 | 72 | $10,210 | $5,692 | 55.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 22 | $7,150 | $3,724 | 52.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 18 | $2,483 | $1,093 | 44.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 11 | 11 | $1,978 | $289.40 | 14.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 98 | 122 | $27,575 | $10,195 | 37.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 64 | $11,549 | $5,762 | 49.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $4,540 | $2,449 | 53.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 24 | $8,180 | $2,382 | 29.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 19 | 21 | $4,851 | $1,439 | 29.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 16 | $3,888 | $900.58 | 23.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 18 | 18 | $2,214 | $803.16 | 36.3% |
About Dr. Roy Bloom, MD
Dr. Roy Bloom, MD is a Nephrology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528093663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Bloom, MD has received a total of $33,677 in payments from pharmaceutical and medical device companies, with $1,500 received in 2020. These payments were reported across 55 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($19,950).
As a Medicare-enrolled provider, Bloom has provided services to 869 Medicare beneficiaries, totaling 1,282 services with total Medicare billing of $121,047. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Philadelphia, PA
- Active Since 07/11/2006
- Last Updated 07/11/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1528093663
Products in Payments
- ENVARSUS (Drug) $9,750
- Envarsus XR (SP) (Drug) $7,569
- Envarsus XR (Drug) $4,196
- Viekira (Drug) $3,120
- Envarsus (Drug) $1,500
- ZEPATIER (Drug) $46.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Philadelphia
Dr. Rakesh Gulati, Md, MD
Nephrology — Payments: $602,663
Nephrology $602,663
Raymond Townsend, Md, MD
Nephrology — Payments: $348,680
Nephrology $348,680
Ellie Kelepouris, Md, MD
Nephrology — Payments: $289,837
Nephrology $289,837
Katalin Susztak, Md, MD
Nephrology — Payments: $164,350
Nephrology $164,350
Jonathan Hogan, Md, MD
Nephrology — Payments: $106,471
Nephrology $106,471
Debbie Cohen Stein, Md, MD
Nephrology — Payments: $92,545
Nephrology $92,545